Clinical trial
Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild…
NCT00495417 · Affiris AG, Industry · Completed
Key facts
| NCT number | NCT00495417 |
|---|---|
| Title | Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease |
| Official title | Randomized, Controlled, Parallel Group, Patient-blinded, Single-center Phase I Pilot Study to Assess Tolerability and Safety of Repeated s.c. Administration of a Single-dose of Affitope AD01 Applied With or Without Adjuvant to Patients With Mild to Moderate Alzheimer's Disease |
| Lead sponsor | Affiris AG, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Biological |
| Interventions | AFFITOPE AD01, AFFITOPE AD01 adjuvanted |
| Enrollment | 24 |
| Start date | Jul 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jul 3, 2007 |
| Last update posted | Oct 19, 2010 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: